The U.S. Food and Drug Administration (FDA) reported on Thursday, March 27 that they are investigating a possible link between Singulair and behavioral changes and suicidality. This investigation is apparently…

As part of ArthroCare Sports Medicine’s recent entry into the Foot and Ankle arena, ArthroCare(R) Corp. (Nasdaq: ARTC) announced today that it has launched early stage clinical and pre-clinical research work for treating diabetic foot ulcers and is encouraged by preliminary results reported by physicians. There are an estimated 18 million Americans living with diabetes today and each year at least 5% of that population develops foot ulcers as an effect of the disease.

Lawmakers earlier this month introduced bills in the House and Senate that would place a three-year moratorium on retroactive repayments from hospice providers to Medicare and authorize a comprehensive study of Medicare hospice benefits, Scripps Howard/Washington Times reports (Collins, Scripps Howard/Washington Times, 3/27).

The Maryland House on Tuesday gave preliminary approval to legislation that would create a program to encourage eligible parents to enroll their children in the Maryland Children’s Health Program, the state’s version of SCHIP, the Washington Post reports.

People who are born prematurely are less likely to have infants of their own later in life and more likely to die during childhood, according to a study published on Wednesday in the Journal of the American Medical Association, USA Today reports (Szabo, USA Today, 3/26). According to the

OXiGENE, Inc.

Medtronic of Canada Ltd. announced that Medtronic, Inc. (NYSE:MDT), has received regulatory approval from Health Canada’s Therapeutic Products Directorate (TPD) for use of the Endeavor drug-eluting coronary stent (DES) system in the treatment of coronary artery disease. The company expects to begin commercial sales of the Endeavor stent in Canada by the end of March.

The Cardiovascular Research Foundation (CRF) will present results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents (DES) versus bare metal stents (BMS) at the Drug-Eluting Stent Revolution VII meeting in Chicago.The analysis - which includes approximately 180,000 patients from 52 studies - was performed by a team of researchers led by Ajay J.

Byram Healthcare, Inc., a leading provider of integrated clinical solutions and medical supplies, announced the national launch of its Latino Diabetes Program. The Byram Latino Diabetes Program provides high-quality, cost-effective care to the U.S. Latino population with diabetes.

Pediatric Weight Management Centers LLC is pleased to introduce Great Moves!, a new weight management program that aims to tackle the obesity epidemic plaguing children, adolescents and their families in the Boston area, and across the U.S. Great Moves! is based in part on a protocol developed at Children’s Hospital Boston. Professional medical services at Great Moves! programs in Massachusetts are provided in collaboration with the physicians of Children’s Hospital Boston.